T. van der Bom MD

foto

MD T. van der Bom

Positions
Other Academic Staff, Medical Specialist
Main activities
Research
Specialisation
Adult congenital heart disease
Focus of research

Therapeutic options in patients with a systemic right ventricle. Currently, we are studying the effects of angiotensin II receptor blocker valsartan in patients with a systemic right ventricle.

Key publications
  • van der Bom Teun, Winter Michiel M., Bouma Berto J., Groenink Maarten, Vliegen Hubert W., Pieper Petronella G., van Dijk Arie P. J., Sieswerda Gertjan T., Roos-Hesselink Jolien W., Zwinderman Aeilko H., Mulder Barbara J. M. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial Circulation 2013;127 (3):322-330 [PubMed]
  • van der Bom Teun, Winter Michiel M., Groenink Maarten, Vliegen Hubert W., Pieper Petronella G., van Dijk Arie P. J., Sieswerda Gertjan T., Roos-Hesselink Jolien W., Zwinderman Aeilko H., Mulder Barbara J. M., Bouma Berto J. Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle Journal of the American College of Cardiology 2013;62 (10):926-936 [PubMed]
  • Winter Michiel M., van der Bom Teun, de Vries Leonie C. S., Balducci Anna, Bouma Berto J., Pieper Petronella G., van Dijk Arie P. J., van der Plas Mart N., Picchio Fernando M., Mulder Barbara J. M. Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial European heart journal 2012;33 (11):1378-1385 [PubMed]
  • van der Bom Teun, Zomer A. Carla, Zwinderman Aeilko H., Meijboom Folkert J., Bouma Berto J., Mulder Barbara J. M. The changing epidemiology of congenital heart disease Nature reviews. Cardiology 2011;8 (1):50-60 [PubMed]
All Publications